Search results for: 'lung in'

15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...

The use case for commercial AI in medical imaging focuses on workflow productivity and diagnostic accuracy in a radiology set up. The impending shortage of radiologists, burnout from a constantly growing imaging workload, and higher investments (by both public and private groups) favor the adoption of AI in medical imaging. Several medical imaging ...

This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and forecasted number of procedures, market size, and revenue forecast in respiratory diagnostics such as computed tomography, magnetic resonance imaging, positron emission t...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

This research service provides an analysis of the procedure volumes and reimbursement trends for heart and lung imaging using magnetic resonance imaging (MRI). Growth opportunities in terms of clinical applications and technologies are provided as well as an overview of unit shipment and revenue forecasts at the global level from 2019 to 2026. Reim...

Global resource constraints on health systems are driving a shift to value-based healthcare to reduce cost, increase access, and improve outcomes. In the United States, resource constraints affect more than 20% of the population. The number of respiratory therapists is declining at a rate of 4% to 7%, while the demand for respiratory specialists wi...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

06 Nov 2017  |  North America  |  Market Research

Global Computed Tomography Market, Forecast to 2021

With Minimal Technological Differentiation, Stake Holders Focus on Value Based Products and Operational Expenditure Models

Infographics

×

The study aims to analyze and forecast the Computed Tomography market in North America (the United States and Canada), Europe and Asia-Pacific countries for 2016. Research Scope: Market trends (Utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changi...

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional rad...